New evidence compares micro-ultrasound and MRI fusion biopsy for detecting clinically significant prostate cancer. Find out ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Under adequate local anesthesia, the size of the transrectal ultrasound probe made no difference to pain perception during transrectal ultrasound guided prostate biopsy, according to a PubMed report.
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
An ultrasound scan can be used to detect cases of prostate cancer, according to new research. Researchers at Imperial College London, University College London and Imperial College Healthcare NHS ...
Feb. 2 (UPI) --An MRI-guided ultrasound treatment is effective against intermediate-risk prostate cancer and causes minimal side effects, according to a study published Tuesday by the journal ...
Precisely delivered ultrasound could be an effective treatment for prostate cancer, with high-frequency sound waves heating and killing off cancer cells, a new study says. The treatment killed off all ...
An ultrasound scan can be used to detect cases of prostate cancer, according to new research. Researchers at Imperial College London, University College London and Imperial College Healthcare NHS ...
Researchers in the UK have demonstrated a new kind of ultrasound scan can diagnose prostate cancer with accuracy equal to costly and time-consuming magnetic resonance imaging (MRI). The findings offer ...
It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...
OAK BROOK, Ill. - A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance effectively treats intermediate-risk prostate cancer with minimal side effects, ...